These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9889969)

  • 1. Immune control of HIV-1 replication.
    Walker BD; Rosenberg ES; Hay CM; Basgoz N; Yang OO
    Adv Exp Med Biol; 1998; 452():159-67. PubMed ID: 9889969
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune control.
    Fornataro K; Jefferys R
    Body Posit; 1999 Mar; 12(3):9-12. PubMed ID: 11366299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.
    Jassoy C; Walker BD
    Springer Semin Immunopathol; 1997; 18(3):341-54. PubMed ID: 9089953
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular immune responses to HIV-1 in progressive and non-progressive infections.
    Bollinger RC; Egan MA; Chun TW; Mathieson B; Siliciano RF
    AIDS; 1996; 10 Suppl A():S85-96. PubMed ID: 8883615
    [No Abstract]   [Full Text] [Related]  

  • 5. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.
    Yang OO; Walker BD
    Adv Immunol; 1997; 66():273-311. PubMed ID: 9328644
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
    Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
    Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic-T-cell responses in early HIV-1 infection.
    Phillips AN
    N Engl J Med; 1998 Feb; 338(9):622-3. PubMed ID: 9480442
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.
    Bucy RP
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):223-7. PubMed ID: 10052752
    [No Abstract]   [Full Text] [Related]  

  • 10. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 12. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?
    Klein MR; van der Burg SH; Pontesilli O; Miedema F
    Immunol Today; 1998 Jul; 19(7):317-24. PubMed ID: 9666605
    [No Abstract]   [Full Text] [Related]  

  • 15. Population dynamics of immune responses to persistent viruses.
    Nowak MA; Bangham CR
    Science; 1996 Apr; 272(5258):74-9. PubMed ID: 8600540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 lymphocytes in HIV infection: helpful and harmful.
    Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
    J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CD8+ T-cell cytotoxicity in HIV-1 infection.
    Saeidi A; Buggert M; Che KF; Kong YY; Velu V; Larsson M; Shankar EM
    Cell Immunol; 2015; 298(1-2):126-33. PubMed ID: 26520669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 evolution and disease progression.
    Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ
    Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.